Magnetic susceptibility of Dy-DTPA-BMA to reperfused myocardial infarction in an excised dog heart model: Evidence of viable myocardium

Chinese Medical Journal

Volumn 113, Issue 3, 2000, Pages 260-264

  Zhao, Shihua ^a   Revel, Didier ^b   Arteaga, Charles ^b   Canet, Emmanuelle ^b   Liu, Shaozhong ^a   Hadour, Guylaine ^b   Forrat, Remy ^c   Oksendal, Audun ^d  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

^d ALTANA PHARMA AG   (Germany)

Author keywords

Contrast medium; Magnetic resonance imaging; Myocardial cell viability; Reperfused myocardial infarction

Indexed keywords

DYSPROSIUM;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; HEART INFARCTION; HEART MUSCLE REPERFUSION; NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANIMALS; CONTRAST MEDIA; DOGS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

EID: 0034023839     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Saeed M, Wendland MF, Higgins CB. Contrast media for MR imaging of the heart. JMRI 1994;4:269-279.
2. De Roos A, Matheijssin NA, Doornbos J, et al. Myocardial infarct size after reperfusion therapy: assessment with Gd-DTPA-enhanced MR imaging. Radiology 1990;176:517-521.
3. Ovize M, Revel D, Lorgeril M, et al. Quantitation of reperfused myocardial infarction by Gd-DOTA-enhanced magnetic resonance imaging: an experimental study. Invest Radiol 1991; 26: 1065-1070.
4. De Roos A, van Rossum AC, van der Wall EE, et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989; 172: 717-720.
5. Saeed M, Wendland MF, Takehara Y, et al. Reperfused and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. Radiology 1992;182:675-683.
6. Masui T, Saeed M, Wendland MF, et al. Occlusive and reperfused myocardial infarcts: MR imaging differentiation with nonionic Gd-DTPA-BMA. Radiology 1991;181:77-83.
7. Yu KK, Saeed M, Wendland MF, et al. Comparison of T1-enhancing and magnetic susceptibility agents for demarcation of the jeopardy area in experimental myocardial infarction. Invest Radiol 1993;28:1015-1023.
8. Saeed M, Wendland MF, Tomei E, et al. Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging. Radiology 1989;173:763-767.
9. Saeed M, Wendland MF, Yu KK, et al. Delineation of acute myocardial infarction with dysprosium DTPA-BMA: influence of dose of magnetic susceptibility contrast medium. J Am Coll Cardiol 1992;20: 1634-1641.
10. Saeed MM, Wendland MF, Masui T, et al. Reperfused myocardial infarction on T1-and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. MRM 1994;31:31-39.
11. Geschwind JFH, Wendland MF, Saeed M, et al. Identification of myocardial cell death in repefused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging. Acad Radiol 1994;1:319-325.
12. Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 1990;8:467-487.
13. Rocklage SM, Watson AD. Chelates of gadolinium and dysprosium as contrast agent for MR imaging. J Magn Reson Imaging 1993;3:167-178.
14. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985;121:522-530.
15. De Roos A, Doornbos J, van der Wall EE, et al. MR imaging of acute myocardial infarction: value of Gd-DTPA. A J R 1988;150:531-534.
16. Roberto B. Mechanism of myocardial "stunning". Circulation 1990;82:723-737.